Skin & Soft Tissue Diseases

Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.

A review of the current literature and future directions.

This breakthrough vaccine is quickly becoming an integral part of the adult immunization arsenal.

Paratek’s omadacycline moves another step toward approval.

The results of a new study reveal that hematopoietic cell transplantation (HCT) may still be successful in cases with incomplete radiographic control of invasive fungal infection (IFI) prior to transplant.

The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.

Positive safety and efficacy results have been seen across 2 different dosing regimens as well as for any effects on QT prolongation.

An Australian study found patients were better informed and more empowered when they signed up for a national registry of spleen disease patients.

In the wake of Europe’s recent 4-fold increase in measles cases, countries such as Italy, Germany, and Romania are passing tougher laws requiring vaccinations for children being enrolled in school.

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.

A rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.

The publication of a new study poses novel questions for dual-use research of concern and if such work should have been published.

Investigators from Massachusetts General Hospital (MGH) have made some interesting findings about methicillin-resistant Staphylococcus aureu (MRSA) that may hold the key to curbing lymphatic repercussions.

Rates of re-hospitalization and long-term health effects remain high among sepsis survivors, which is why researchers are outlining ways to help sepsis patients after hospital discharge.

Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.

Plazomicin is a next-generation aminoglycoside with in vitro activity against multidrug-resistant Enterobacteriaceae.

Could 2018 finally be the year polio is eliminated as a global health concern?

Researchers have found that the 4-component vaccine MenB-4C (Bexsero) is effective against up to 91% of strains of the bacteria Neisseria meningitidis, which causes meningococcal disease.

A review in Trends in Microbiology provides insight into the role of biofilms in the pathogenesis of polymicrobial infectious diseases.

The FDA has approved Shingrix, GlaxoSmithKline’s recombinant zoster vaccine against shingles, for patients 50 and older.

Why is delafloxacin unique compared to other fluoroquinolones? Find out more.

Bacterial vaginosis is the most common gynecologic infection in the United States, affecting 21 million women between the ages of 14 and 49, each year.

A new study looks at the role the microbiome of the middle ear may play in ear infections.

Daniel Pilch, PhD, explains which patients would not make good candidates for MRSA prodrug TXA709.

A measles outbreak that affected 79 individuals in the state of Minnesota this spring and summer 2017 was recently declared “over” by the Minnesota Department of Health (MDH).

Proton pumps inhibitors present risks for individuals living with HIV, dalbavancin can treat MRSA-related pneumonia, probiotics prove deadly against C. difficile, patient involvement increases healthcare practitioners’ hand hygiene, and why delafloxacin is a unique antibiotic for skin infections are the topics that make up this week’s Top 5 articles.